EM2AI currently sells and distributes its AI solutions in Singapore and Malaysia. Founded in 2018 and headquartered in Singapore, EM2AI has developed healthcare software for the dental industry, which it claims can serve as a “second opinion to increase diagnosis accuracy”.
EM2AI, a 49% associated company of Mainboard-listed Q&M Dental, has entered a memorandum of understanding (MOU) with a dental solutions provider to use its dental artificial intelligence (AI) solutions across 1,000 dental clinics in the region.
This follows EM2AI’s announcement on Jan 13, about securing medical device licences in four Asean markets — Thailand, Vietnam, Indonesia and the Philippines.
